A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D)

CompletedOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

December 21, 2020

Primary Completion Date

September 9, 2023

Study Completion Date

September 5, 2024

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

BAY81-9783 (Acarbose/Metformin)

Tablet (FDC of 25/50mg acarbose + 500mg metformin), three times daily

Trial Locations (1)

Many locations, Multiple Locations